FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to the recombinant production of human heat shock protein 70 (HTS70), and can be used to produce HTS70 in milk of transgenic animals. A human HSP70 with SEQ ID NO.: 1, characterized by mutations in glycosylation sites, that do not affect the chaperone properties of the protein and allow to prevent the posttranslational modification, not characteristic of intracellular forms of HTS70, which usually occurs during the production of recombinant HSP70 in transgenic animals’ milk.
EFFECT: invention makes it possible to obtain a human HSP70, having the chaperone properties of native human HSP70 in the milk of transgenic animals.
2 cl, 8 dwg, 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
GENETIC STRUCTURE RBCT70 FOR EXPRESSION OF THE MAIN HUMAN STRESS PROTEIN IN MILK OF TRANSGENIC ANIMALS | 2015 |
|
RU2644663C2 |
METHOD OF THERAPY OF MALIGNANT DISEASES | 2013 |
|
RU2597414C2 |
STRAIN OF Escherichia coli BACTERIA - PRODUCENT OF HEAT SHOCK PROTEIN 70 AND METHOD FOR OBTAINING PREPARATION OF HUMAN HEAT SHOCK PROTEIN | 2013 |
|
RU2564120C2 |
METHOD FOR BIOPROTECTION BASED ON UTILIZATION OF SPECIFIC PREPARATION NAMED AS BTSH70 FOR CREATING OF AGENTS AND METHODS FOR NON-SPECIFIC PROTECTION FROM DANGEROUS DAMAGE EFFECT | 2005 |
|
RU2294210C1 |
EXPRESSION VECTOR STRUCTURE, NEW METHODS FOR OBTAINING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT OBTAINING OF POLYPEPTIDES | 2012 |
|
RU2628703C2 |
METHOD OF STIMULATING ANTI-TUMOUR ACTIVITY OF CYTOTOXIC EFFECTORS OF IMMUNE SYSTEM | 2010 |
|
RU2429005C1 |
EXPRESSION VECTOR ELEMENT COMBINATION, NEW METHODS FOR OBTAINING PRODUCER CELLS AND THEIR APPLICATION FOR RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2012 |
|
RU2639519C2 |
VARIANTS OF LIPASE STIMULATING BY BILE SALTS, DNA ENCODING THEREOF AND TRANSGENE MAMMALS NO BELONGING TO HUMANS | 1994 |
|
RU2219239C2 |
PRODUCTION OF VIRUS-LIKE PARTICLES IN PLANTS | 2011 |
|
RU2655431C2 |
ALPHA-ENOLASE SPECIFIC ANTIBODIES AND METHODS OF USES IN CANCER THERAPY | 2013 |
|
RU2656153C1 |
Authors
Dates
2018-03-16—Published
2016-06-29—Filed